Navin Fluorine International Limited informed that the Board of Directors of the Company have, made the following decisions at its Meeting held on February 06, 2024. The Board has approved Capital Expenditure of: (a) INR 2,880 million for new cGMP-4 facility at Dewas unit of the Company, to be spent in two or more phases; and (b) INR 840 million for expansion of HFC capacity at Surat unit of the Company. Details of Capital Expenditure of INR 2,880 million for new cGMP-4 facility at Dewas: Existing Capacity-This is a new capacity.

Existing Capacity Utilization-Not applicable. Proposed Capacity Addition -200KL (in phases). Period within which the proposed capacity is to be added- 25-30 months.

Investment required- INR 2,880 million. Mode of financing-Internal accruals. Rationale-Cater to envisaged growth in the business.

Details of Capital Expenditure of INR 840 million for expansion of HFC capacity at Surat: Existing Capacity -4,500 TPA. Existing Capacity Utilization-90%. Proposed Capacity Addition -4,500 TPA.

Period within which the proposed capacity is to be added- 12 months. Investment required- INR 840 million. Mode of financing-Internal accruals.

Rationale -Cater to the growing demand from the domestic and export markets.